Skip to main content
. Author manuscript; available in PMC: 2016 Mar 29.
Published in final edited form as: Int J Cancer. 2012 Mar 28;131(9):2008–2015. doi: 10.1002/ijc.27493

Figure 2.

Figure 2

Mean body weights, measured weekly, in male B6C3F1 mice administered 0.14 or 0.70 mmol acrylamide or glycidamide per kg body weight, or the vehicle, intraperitoneally on PNDs 1, 8, and 15. (◆) 0.14 mmol acrylamide per kg body weight; (■) 0.70 mmol acrylamide per kg body weight; (▲) 0.14 mmol glycidamide per kg body weight; (×) 0.70 mmol glycidamide per kg body weight; (*) vehicle.